Deirdre Albertson
Jamie White
Cheryl Kerr
Dr. Nieca Goldberg
Christine Lemke
Temitayo Erogbogbo
Rafael Seixas
Rafael is Membership Manager at Bonsucro, the global sugarcane platform, where he has been working since 2012. He is responsible for ensuring value to members, developing the membership engagement strategy and demonstrating impacts to stakeholders, driving uptake and commitment.
Before joining Bonsucro he was a Chevening scholar at University College London and worked for 4 years as International Relations Advisor to the City Hall of Sao Paulo, Brazil. He holds a bachelor’s degree in International Relations and a master’s degree in International Public Policy
Christophe Carrié
Christophe Carrié started working for Plansee in Austria in 2007 in sales of molybdenum and tungsten-based materials. From 2010 he spent 5 years as Key Account Manager Europe for Plansee in the Power Transmission and Distribution business unit before being appointed Product Development Manager Europe in 2015. In 2017 he became Head of Business Development. In 2021 he joined Matmatch as CEO, based in Munich, Germany
Oliver Peoples
Oliver P. Peoples, Ph.D. is the President and Chief Executive Officer of Yield10 Bioscience. Previously, Dr. Peoples was a co-founder of Metabolix and served as its Chief Scientific Officer and Vice President of Research and Development from January 2000 until October 2016, and also served as director of the Company since June 1992.
Prior to founding Metabolix, Dr. Peoples was a research scientist with the Department of Biology at the Massachusetts Institute of Technology where he emerged as a pioneer of the new field of metabolic pathway engineering and its applications in industrial biotechnology. The research carried out by Dr. Peoples at MIT established the fundamental tools and methods for engineering bacteria and plants to produce Mirel biopolymers. Dr. Peoples has published numerous peer reviewed academic papers and is an inventor of over 90 patents and patent applications worldwide. Dr. Peoples received a Ph.D. in Molecular Biology from the University of Aberdeen, Scotland.